Selective preoperative cardiac screening improves five-year survival in patients undergoing major vascular surgery: A cost-effectiveness analysis

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 3, 1999, Pages 265-271

  Glance, Laurent G ^a,b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

Coronary artery disease; Cost effectiveness analysis; Vascular disease

Indexed keywords

DIPYRIDAMOLE; THALLIUM;

ADULT; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCREENING; SURVIVAL RATE; VASCULAR SURGERY;

EID: 0033020125     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90261-6     Document Type: Article

References (27)

1. Fleisher LA, Skolnick ED, Lehman HP: Coronary artery revascularization before AAA surgery: A decision analytic approach. Anesth Analg 79:661-669, 1994
2. Hertzer NR: Basic data underlying decision making clinical vascular surgery. Ann Vasc Surg 1:616-620, 1987
3. Hertzer NR, Beven EG, Young JR et al: Coronary artery disease in peripheral vascular patients: A classification of 1,000 coronary angiograms and results of surgical management. Ann Surg 199:223-233, 1984
4. Gersh BJ, Rihal CS, Rooke TW, Ballard DJ: Evaluation and management of patients with peripheral vascular and coronary artery disease. J Am Coll Cardiol 18:203-214, 1991
5. Birkmeyer JD, O'Connor FT, Quinton HB, et al: The effect of peripheral vascular disease on in-hospital mortality rates with coronary bypass surgery. J Vasc Surg 21:445-452, 1995
6. Mason JJ, Owens DK, Harris RA, et al: The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA 273:1919-1925, 1995
7. Eagle KA, Burndage BH, Chaitman BR, et al: Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Circulation 93:1278-1317, 1996
8. Sonnenberg FA, Beck JR: Markov models in medical decision making: A practical guide. Med Decis Making 13:322-338, 1993
9. Rihal CS, Eagle KA, Mickel MC, et al: Surgical therapy for coronary artery disease among patients with combined coronary artery and peripheral vascular disease. Circulation 91:46-53, 1995
10. Beck JR, Pauker SG, Gottlieb JE, et al: A convenient approximation of life expectancy. Am J Med 73:889-897, 1982
11. Alderman EL, Bourassa MG, Cohen LS, et al: Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation 82:1629-1646, 1990
12. Statistical Abstract of the U.S., 1996. www.census.gov/statab/WWW/
13. Eagle KA, Rihal CS, Mickel MC, et al: Cardiac risk of noncardiac surgery: Influence of coronary disease and type of surgery in 3,368 operations. Circulation 96:1882-1887, 1997
14. Eagle KA, Coley CM, Newell JB, et al: Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Int Med 110:859-866, 1989
15. L'Italien GJ, Paul SD, Hendel RC, et al: Development and validation of a bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical candidates. J Am Coll Cardiol 27:779-786, 1996
16. Chaitman BR, Bourassa MG, Davis K, et al: Angiographie prevalence of high-risk coronary artery disease in Patient Subsets (CASS). Circulation 64:360-367, 1981
17. Manning WG, Fryback DG, Weinstein MC, et al: Reflecting uncertainty in cost-effectiveness analysis, in Gold MR, Marthe R (eds): Cost-Effectiveness in Health and Medicine, New York, NY Oxford University Press, 1996, pp 247-275
18. Fleisher LA, Eagle KA: Screening for cardiac disease in patients having noncardiac surgery. Ann Intern Med 124:767-772, 1996
19. Solomon AJ, Gersh BJ: Ischemic heart disease: Surgical options, in Antman EM, Bittl JA, Colucci WS, et al (eds): Cardiovascular Therapeutics. Philadelphia, PA, WB Saunders, 1996, pp 65-80
20. Roger VL, Ballard DJ, Hallett JW, et al: Influence of coronary artery disease on morbidity and mortality after abdominal aortic aneurysmectomy: A population-based study, 1971-1987. J Am Coll Cardiol 14:1245-1252, 1989
21. Goldman L, Gordon DJ, Rifkind DM, et al: Cost and health implications of cholesterol lowering. Circulation 85:1960-1968, 1992
22. Yusuf S, Zucker D, Peduzzi P, et al: Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomized trials by the Coronary Artery Bypass Surgery Trialist Collaboration. Lancet 344:563-570, 1994
23. Jansson K, Fransson S: Mortality related to coronary angiography. Clin Radiol 51:858-860, 1996
24. Patterson RE, Eisner RL, Horowitz SF: Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 91:54-65, 1995
25. Hlatky MA, Rogers WJ, Johnstone I, et al: Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 336:92-99, 1997
26. Mark DB, Naylor CD, Hlatky MA, et al: Use of medical resources and quality of life after acute myocardial infarction in Canada and die United States. N Engl J Med 331:1130-1135, 1994
27. Petitti DB: Meta-analysis, decision analysis and cost-effectiveness analysis. New York, NY Oxford University Press, 1994, p 181